Jie Wu

Jie Wu

Auto-generated profile, based on publicly available information

Jie Wu

Department of Biological Chemistry, University of California, Irvine, CA 92697, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RLRyan G. Lim
Ryan G. Lim
OAOsama Al-Dalahmah
Osama Al-Dalahmah
JWJie Wu
Jie Wu
MGMaxwell P. Gold
Maxwell P. Gold
JRJack C. Reidling
Jack C. Reidling
LTLeslie M. Thompson
Leslie M. Thompson
The complexity of affected brain regions and cell types is a challenge for Huntington’s disease (HD) treatment. Here we use single nucleus RNA sequencing to investigate molecular pathology in the cortex and striatum from R6/2 mice and human HD post-mortem tissue. We identify cell type-specific and -agnostic signatures suggesting oligodendrocytes (OLs) and oligodendrocyte precursors (OPCs) are arrested in intermediate maturation states. OL-lineage regulatorsOLIG1andOLIG2are negatively correlated with CAG length in human OPCs, and ATACseq analysis of HD mouse NeuN-negative cells shows decreased accessibility regulated by OL maturation genes. The data implicates glucose and lipid metabolism in abnormal cell maturation and identifyPRKCEand Thiamine Pyrophosphokinase 1 (TPK1) as central genes. Thiamine/biotin treatment of R6/1 HD mice to compensate forTPK1dysregulation restores OL maturation and rescues neuronal pathology. Our insights into HD OL pathology spans multiple brain regions and link OL maturation deficits to abnormal thiamine metabolism.

14 December 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PSPeng Sun
Peng Sun
RVRemy Vu
Remy Vu
MDMorgan Dragan
Morgan Dragan
DHDaniel Haensel
Daniel Haensel
GGGuadalupe Gutierrez
Guadalupe Gutierrez
XDXing Dai
Xing Dai

15 January 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
AKAmanda J Kedaigle
Amanda J Kedaigle
JRJack C Reidling
Jack C Reidling
RLRyan G Lim
Ryan G Lim
MAMiriam Adam
Miriam Adam
JWJie Wu
Jie Wu
LTLeslie M Thompson
Leslie M Thompson
Transcriptional and epigenetic alterations occur early in Huntington’s disease (HD), and treatment with epigenetic modulators is beneficial in several HD animal models. The drug JQ1, which inhibits histone acetyl-lysine reader bromodomains, has shown promise for multiple cancers and neurodegenerative disease. We tested whether JQ1 could improve behavioral phenotypes in the R6/2 mouse model of HD and modulate HD-associated changes in transcription and epigenomics. R6/2 and non-transgenic (NT) mice were treated with JQ1 daily from 5 to 11 weeks of age and behavioral phenotypes evaluated over this period. Following the trial, cortex and striatum were isolated and subjected to mRNA-seq and ChIP-seq for the histone marks H3K4me3 and H3K27ac. Initially, JQ1 enhanced motor performance in NT mice. In R6/2 mice, however, JQ1 had no effect on rotarod or grip strength but exacerbated weight loss and worsened performance on the pole test. JQ1-induced gene expression changes in NT mice were distinct from those in R6/2 and primarily involved protein translation and bioenergetics pathways. Dysregulation of HD-related pathways in striatum was exacerbated by JQ1 in R6/2 mice, but not in NTs, and JQ1 caused a corresponding increase in the formation of a mutant huntingtin protein-dependent high molecular weight species associated with pathogenesis. This study suggests that drugs predicted to be beneficial based on their mode of action and effects in wild-type or in other neurodegenerative disease models may have an altered impact in the HD context. These observations have important implications in the development of epigenetic modulators as therapies for HD.

22 December 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SHSarah J Hernandez
Sarah J Hernandez
RLRyan G Lim
Ryan G Lim
TOTarik Onur
Tarik Onur
MDMark A Dane
Mark A Dane
RSRebecca Smith
Rebecca Smith
LTLeslie M Thompson
Leslie M Thompson
Astrocytes and brain endothelial cells are components of the neurovascular unit that comprises the blood–brain barrier (BBB) and their dysfunction contributes to pathogenesis in Huntington’s disease (HD). Defining the contribution of these cells to disease can inform cell-type-specific effects and uncover new disease-modifying therapeutic targets. These cells express integrin (ITG) adhesion receptors that anchor the cells to the extracellular matrix (ECM) to maintain the integrity of the BBB. We used HD patient-derived induced pluripotent stem cell (iPSC) modeling to study the ECM–ITG interface in astrocytes and brain microvascular endothelial cells and found ECM–ITG dysregulation in human iPSC-derived cells that may contribute to the dysfunction of the BBB in HD. This disruption has functional consequences since reducing ITG expression in glia in an HD Drosophila model suppressed disease-associated CNS dysfunction. Since ITGs can be targeted therapeutically and manipulating ITG signaling prevents neurodegeneration in other diseases, defining the role of ITGs in HD may provide a novel strategy of intervention to slow CNS pathophysiology to treat HD.

7 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DCDaniel Chow
Daniel Chow
JSJennifer E. Soun
Jennifer E. Soun
JGJustin Glavis-Bloom
Justin Glavis-Bloom
Brent WeinbergBrent Weinberg
Brent Weinberg
PCPeter D. Chang
Peter D. Chang
BBBernadette Boden-Albala
Bernadette Boden-Albala
Background: Recent epidemiological evidence has demonstrated a higher rate of COVID-19 hospitalizations and deaths among minorities. This pattern of race-ethnic disparities emerging throughout the United States raises the question of what social factors may influence spread of a highly transmissible novel coronavirus. The purpose of this study is to describe race-ethnic and socioeconomic disparities associated with COVID-19 in patients in our community in Orange County, California and understand the role of individual-level factors, neighborhood-level factors, and access to care on outcomes. Methods: This is a case-series of COVID-19 patients from the University of California, Irvine (UCI) across six-weeks between 3/12/2020 and 4/22/2020. Note, California’s shelter-in-place order began on 3/19/2020. Individual-level factors included race-ethnicity status were recorded. Neighborhood-level factors from census tracts included median household income, mean household size, proportion without a college degree, proportion working from home, and proportion without health insurance were also recorded. Results: A total of 210-patients tested were COVID-19 positive, of which 73.3% (154/210) resided in Orange County. Hispanic/Latinx patients residing in census tracts below the median income demonstrated exponential growth (rate = 55.9%, R2 = 0.9742) during the study period. In addition, there was a significant difference for both race-ethnic (p < 0.001) and income bracket (p = 0.001) distributions prior to and after California’s shelter-in-place. In addition, the percentage of individuals residing in neighborhoods with denser households (p = 0.046), lower levels of college graduation (p < 0.001), health insurance coverage (p = 0.01), and ability to work from home (p < 0.001) significantly increased over the same timeframe. Conclusions and Relevance: Our study examines the race-ethnic disparities in Orange County, CA, and highlights vulnerable populations that are at increased risk for contracting COVID-19. Our descriptive case series illustrates that we also need to consider socioeconomic factors, which ultimately set the stage for biological and social disparities.

18 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
LFLaiyi Fu
Laiyi Fu
YCYingxin Cao
Yingxin Cao
JWJie Wu
Jie Wu
QPQinke Peng
Qinke Peng
QNQing Nie
Qing Nie
XXXiaohui Xie
Xiaohui Xie
Motivation: For many RNA molecules, the secondary structure is essential for the correct function of the RNA. Predicting RNA secondary structure from nucleotide sequences is a long-standing problem in genomics, but the prediction performance has reached a plateau over time. Traditional RNA secondary structure prediction algorithms are primarily based on thermodynamic models through free energy minimization, which imposes strong prior assumptions and is slow to run. Results: Here we propose a deep learning-based method, called UFold, for RNA secondary structure prediction, trained directly on annotated data without any thermodynamic assumptions. UFold improves substantially upon previous models, with approximately 10~30% improvement over traditional thermodynamic models and 14% improvement over other learning-based methods. It achieves an F1 score of 0.91 on base pair prediction accuracy on an RNA structure prediction benchmark dataset. UFold is also fast with an inference time about 160ms per sequence up to 1600bp length. We provide an online web server that implements UFold for RNA structure prediction and is made freely available. Availability: An online web server running UFold is available at https://ufold.ics.uci.edu . Code is available at https://github.com/uci-cbcl/UFold . Contact: xhx@uci.edu